Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan), which inhibits active tubular secretion of organic acids, increasing their plasma concentration, and is beneficial in treating gout by suppressing uric acid reabsorption.

The rate of active tubular secretion is directly dependent on renal plasma flow (RPF). Drugs like p-aminohippuric acid (PAH) and iodopyracet (Diodrast) are frequently used to measure active tubular secretion. Both are filtered by glomeruli, secreted by tubular cells, and eliminated in a single pass. Their clearance reflects the effective renal plasma flow (ERPF), which ranges from 425 to 650 mL/min. ERPF is determined by RPF, and the fraction of the drug effectively extracted by the kidney is relative to the concentration in the renal artery.

Interestingly, the elimination half-life of drugs excreted solely by active secretion is minimally affected by drug-protein binding. For instance, although extensively protein-bound, penicillins have short half-lives due to rapid elimination by active secretion.

From Chapter 6:

article

Now Playing

6.6 : Renal Drug Excretion: Tubular Secretion

Pharmacokinetics: Drug Excretion and Clearance

36 Views

article

6.1 : Drug Elimination: Overview

Pharmacokinetics: Drug Excretion and Clearance

69 Views

article

6.2 : Elimination Kinetics: First-Order and Zero-Order

Pharmacokinetics: Drug Excretion and Clearance

92 Views

article

6.3 : Renal Drug Excretion: Overview

Pharmacokinetics: Drug Excretion and Clearance

38 Views

article

6.4 : Renal Drug Excretion: Glomerular Filtration

Pharmacokinetics: Drug Excretion and Clearance

53 Views

article

6.5 : Renal Drug Excretion: Tubular Reabsorption

Pharmacokinetics: Drug Excretion and Clearance

36 Views

article

6.7 : Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Pharmacokinetics: Drug Excretion and Clearance

45 Views

article

6.8 : Hepatic Drug Excretion: Enterohepatic Cycling

Pharmacokinetics: Drug Excretion and Clearance

41 Views

article

6.9 : Hepatic Drug Excretion: Influencing Factors

Pharmacokinetics: Drug Excretion and Clearance

35 Views

article

6.10 : Drug Excretion: Pulmonary and Glandular Routes

Pharmacokinetics: Drug Excretion and Clearance

14 Views

article

6.11 : Drug Excretion: Miscellaneous Routes

Pharmacokinetics: Drug Excretion and Clearance

13 Views

article

6.12 : Drug Clearance: Overview

Pharmacokinetics: Drug Excretion and Clearance

21 Views

article

6.13 : Clearance Models: Physiological Models

Pharmacokinetics: Drug Excretion and Clearance

32 Views

article

6.14 : Clearance Models: Compartment Models

Pharmacokinetics: Drug Excretion and Clearance

28 Views

article

6.15 : Clearance Models: Noncompartmental Models

Pharmacokinetics: Drug Excretion and Clearance

18 Views

See More

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved